Literature DB >> 33076809

Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.

Le-Yi Zhang1, Jun-Gang Zhang2,3, Xue Yang3, Mao-Hua Cai1, Cheng-Wu Zhang2,3, Zhi-Ming Hu2,3.   

Abstract

Traditional Chinese Medicine (TCM) is one of the ancient and most accepted alternative medicinal systems in the world for the treatment of health ailments. World Health Organization recognizes TCM as one of the primary healthcare practices followed across the globe. TCM utilizes a holistic approach for the diagnosis and treatment of cancers. The tumor microenvironment (TME) surrounds cancer cells and plays pivotal roles in tumor development, growth, progression, and therapy resistance. TME is a hypoxic and acidic environment that includes immune cells, pericytes, fibroblasts, endothelial cells, various cytokines, growth factors, and extracellular matrix components. Targeting TME using targeted drug delivery and nanoparticles is an attractive strategy for the treatment of solid tumors and recently has received significant research attention under precise medicine concept. TME plays a pivotal role in the overall survival and metastasis of a tumor by stimulating cell proliferation, preventing the tumor clearance by the immune cells, enhancing the oncogenic potential of the cancer cells, and promoting tumor invasion. Hepatocellular Carcinoma (HCC) is one of the major causes of cancer-associated deaths affecting millions of individuals worldwide each year. TCM herbs contain several bioactive phytoconstituents with a broad range of biological, physiological, and immunological effects on the system. Several TCM herbs and their monomers have shown inhibitory effects in HCC by controlling the TME. This study reviews the fundamentals and applications of targeting strategies for immunosuppressing TME to treat cancers. This study focuses on TME targeting strategies using TCM herbs and the molecular mechanisms of several TCM herbs and their monomers on controlling TME. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Angiogenesis inhibitors; Hepatocellularzzm321990carcinoma; Immunomodulation; Immunosuppressing; Targeting strategies; Traditional chinese medicine; Tumor microenvironment

Mesh:

Substances:

Year:  2020        PMID: 33076809     DOI: 10.2174/1568026620666201019111524

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

Review 1.  The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma.

Authors:  Kaiting Wang; Xinyao Qiu; Yan Zhao; Hongyang Wang; Lei Chen
Journal:  Cancer Biol Med       Date:  2021-10-01       Impact factor: 4.248

2.  Effects of Traditional Chinese Medicine Adjuvant Therapy on the Survival of Patients with Primary Liver Cancer.

Authors:  Jie Hou; Ke Shi; Yao Liu; Jialiang Chen; Chongping Ran; Xianbo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-17       Impact factor: 2.629

3.  Immune-Related lncRNA Pairs Clinical Prognosis Model Construction for Hepatocellular Carcinoma.

Authors:  Yinghui Zhu; Dezhi Shan; Lianyi Guo; Shujia Chen; Xiaofei Li
Journal:  Int J Gen Med       Date:  2022-02-22

Review 4.  Immunomodulatory Effect of Traditional Chinese Medicine Combined with Systemic Therapy on Patients with Liver Cancer: A Systemic Review and Network Meta-analysis.

Authors:  Qing Pu; Lihua Yu; Xinhui Wang; Huiwen Yan; Yuqing Xie; Yuyong Jiang; Zhiyun Yang
Journal:  J Cancer       Date:  2022-09-06       Impact factor: 4.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.